Suchergebnisse - "Suri, Vithika"

PubPharm (25)

1

Blocking viral entry with bulevirtide reduces the number of HDV-infected hepatocytes in human liver biopsies

enthalten in: Journal of hepatology | 2024

von Allweiss, L. | Volmari, A. | Suri, V. | +9

2

No virologic resistance to bulevirtide monotherapy detected in patients through 24 weeks treatment in phase II and III clinical trials for chronic hepatitis delta

enthalten in: Journal of hepatology | 2023

von Hollnberger, J. | Liu, Y. | Xu, S. | +22

3

Efficacy and safety of sofosbuvir-velpatasvir and sofosbuvir-velpatasvir-voxilaprevir for hepatitis C in Korea : a Phase 3b study

enthalten in: The Korean journal of internal medicine | 2023

von Heo, J. | Kim, Y. | Lee, S. | +22

CommentIn: Korean J Intern Med. 2023 Jul;38(4):454-455. - PMID 37424499

4

A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D

enthalten in: The New England journal of medicine | 2023

von Wedemeyer, H. | Aleman, S. | Brunetto, M. | +40

CommentIn: N Engl J Med. 2023 Sep 28;389(13):1247-1248. - PMID 37754293

5

Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cells

enthalten in: JHEP reports : innovation in hepatology | 2023

von Aggarwal, A. | Odorizzi, P. | Brodbeck, J. | +15

6

Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D HBeAg-positive chronic hepatitis B

enthalten in: Alimentary pharmacology & therapeutics | 2023

von Wagner, J. | Yuen, L. | Littlejohn, M. | +17

CommentIn: Aliment Pharmacol Ther. 2023 Mar;57(5):581-582. - PMID 36786460

7

Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D HBeAg‐positive chronic hepatitis B

enthalten in: Alimentary Pharmacology & Therapeutics | 2023

von Wagner, J. | Yuen, L. | Littlejohn, M. | +17

8

Sofosbuvir-velpatasvir in adults with hepatitis C virus infection and compensated cirrhosis in Japan

enthalten in: Hepatology research : the official journal of the Japan Society of Hepatology | 2022

von Takehara, T. | Izumi, N. | Mochida, S. | +12

9

International multicenter validation of GES score for HCC risk stratification in chronic hepatitis C patients

enthalten in: Journal of viral hepatitis | 2022

von Shiha, G. | Soliman, R. | Mikhail, N. | +30

10

Ledipasvir/Sofosbuvir for Patients Coinfected With Chronic Hepatitis C and Hepatitis B in Taiwan : Follow-up at 108 Weeks Posttreatment

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Liu, C. | Sheen, I. | Chen, C. | +19